Biomerica Inc (BMRA) stock
BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3049% below fair value
$1.09−0.15 (-11.74%)
Close on Nov 18, 2026Market cap $5.01MP/E –Yield –
Biomerica market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Biomerica's market cap was $6.94M on Nov 11, 2026, against $6.67M a year earlier. Over the last 5 years it ranged from $4.76M to $56.73M, with a median of $10.40M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $6.94M | -2.1% |
| 2025 | Dec 31, 2025 | $7.09M | +40.5% |
| 2024 | Dec 31, 2024 | $5.05M | -76.0% |
| 2023 | Dec 29, 2023 | $21.03M | -53.2% |
| 2022 | Dec 30, 2022 | $44.91M | -7.7% |
| 2021 | Dec 31, 2021 | $48.66M | -16.9% |
| 2020 | Dec 31, 2020 | $58.53M | +98.1% |
| 2019 | Dec 31, 2019 | $29.54M | +94.1% |
| 2018 | Dec 31, 2018 | $15.22M | -52.2% |
| 2017 | Dec 29, 2017 | $31.84M | +69.4% |
| 2016 | Dec 30, 2016 | $18.79M | +92.1% |
| 2015 | Dec 31, 2015 | $9.78M | +45.6% |
| 2014 | Dec 31, 2014 | $6.72M | +18.4% |
| 2013 | Dec 31, 2013 | $5.68M | -2.8% |
| 2012 | Dec 31, 2012 | $5.84M | +77.1% |
| 2011 | Dec 30, 2011 | $3.30M | – |
See a number that looks wrong?